Chargement en cours...
Irinotecan monotherapy offers advantage over combination therapy with irinotecan plus cisplatin in second-line setting for treatment of advanced gastric cancer following failure of fluoropyrimidine-based regimens
The optimal regimen of chemotherapy for gastric cancer in a second-line setting remains to be clarified. The aim of this retrospective study was to evaluate the efficacy and safety of second-line irinotecan treatment. A total of 134 patients with gastric cancer who had received prior chemotherapy wi...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
D.A. Spandidos
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3410594/ https://ncbi.nlm.nih.gov/pubmed/22866071 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.242 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|